Page 2 - Scientific Library
3 solutions for optimal cryopreservation of mammalian cells and tissues
Cell viability after cryopreservation is a sensitive subject as it may be dependent on the ability of mammalian cells to face the stress generated by the freeze / thaw cycles. Improving
ELISA : Quality Control and Performance Evaluation
The ELISA test (acronym of Enzyme Linked ImmunoSorbent Assay) is a test principally used In immunology to detect and/or assay a protein, antigen or antibody in a biological fluid sample . It has many practical
New cancer treatment may reawaken the immune system
Cancer is a disease caused by abnormal cell growth. The cells’ genetic material is corrupted and the metabolic processes do not interact well with them anymore. They grow unchecked, mostly in the form
Accelerate Your Oncology Research With Advanced Solutions
Your source for comprehensive tools, services, and insights for the latest cancer research
Master ADME-Tox Research with Expert Products & Services
Gain insights, explore essential tools, and discover reliable services to drive your ADME-Tox research success.
Empowering Immunology Research with Precision Products and Services
Elevate Your Proteomic Research with Tebubio’s Biomarker & Biostatistics Expertise
Access an engaging on-demand webinar to discover how our Europe-based Contract Research Service Laboratory Platform, led by a team of expert scientists and biostatisticians, can help you overcome challenges
Biological samples solutions: the chalenges of in vitro models
Access this on-demand webinar to discover how Tebubio leverages its expertise to help you source high-quality human biological samples, enabling you to develop the in-vitro model best suited to your research
Accelerate your mRNA-based proof-of-concepts studies with Tebubio
Watch this on-demand webinar to learn how Tebubio's Contract Research Service laboratory and experts can help you overcome the key challenges in developing innovative mRNA-based therapies.
Enhance Your Therapeutic mRNA Research Projects with Modified NTPs
How Modified NTPs are Revolutionising mRNA Vaccine Technology
In recent years, the spotlight on mRNA (messenger RNA) technology has intensified, largely due to its pivotal role
Optimising mRNA for Therapeutics: The Synergy of CleanCap Technology and Minimal UTRs
mRNA and UTRs: Unlocking New Frontiers in Therapeutic Innovation
Over the past five years, there has been an explosive surge in scientific interest surrounding messenger RNA (mRNA),